GCT1015-07/ENGOT-cx12/GOG-3037

Trial Description: 
A Randomized, Open-Label, Phase 3 Trial of Tisotumab Vedotin vs Investigator's Choice Chemotherapy in Second- or Third-Line Recurrent or Metastatic Cervical Cancer
Lead Cooperative Group: 
Participating Groups: 
Trial Number: 

EudraCT Number: 2019-001655-39

Disease Site: 
Cervical
Trial Status: 
Pending
Contact person: